Purchases and Sales Made in Q3 2024 in Lumos Pharma, Inc. (LUMO)
This table provides information about the institutional ownership of Lumos Pharma, Inc. (LUMO) during Q3 2024. The information is specifically focused on institutions that hold shares of LUMOS PHARMA, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 22, 2024
Q3 2024
|
Private Advisor Group, LLC
|
BUY
|
- |
715K+ 2380.64% |
$1.04M - $2.89M
|
745K
$3.23M
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
10KNew |
$14.5K - $40.5K
|
10K
$43.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
6.56KNew |
$9.51K - $26.6K
|
6.56K
$28.5K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
4.42K+ 8.72% |
$6.41K - $17.9K
|
55.1K
$239K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 13, 2024
Q3 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-20- 6.45% |
$29 - $81
|
290
$1.26K
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-28- 35.9% |
$40.6 - $113
|
50
$217
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-111- 40.07% |
$161 - $450
|
166
$720
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-2K- 0.93% |
$2.9K - $8.1K
|
214K
$928K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.36K- 65.8% |
$3.42K - $9.55K
|
1.23K
$5.32K
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-4.31K- 14.56% |
$6.25K - $17.5K
|
25.3K
$110K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-7.82K- 41.25% |
$11.3K - $31.7K
|
11.1K
$48.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-8K- 28.94% |
$11.6K - $32.4K
|
19.6K
$85.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-44.4K- 10.92% |
$64.4K - $180K
|
362K
$1.57M
|
|
|
Nov 14, 2024
Q3 2024
|
Lion Point Capital, LP
New York, NY |
SELL
|
- |
-51.2K- 56.4% |
$74.2K - $207K
|
39.6K
$172K
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-350K- 84.34% |
$508K - $1.42M
|
65K
$282K
|